title: Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
authors.affiliation: Transplant Unit, Hospital Geral de Fortaleza, Brazil.
authors.forename: R M
authors.initials: RM
authors.lastname: Esmeraldo
authors.forename: M O
authors.initials: MO
authors.lastname: Donadi
authors.forename: M L
authors.initials: ML
authors.lastname: Oliveira
authors.forename: C N
authors.initials: CN
authors.lastname: Ponte
authors.forename: P M
authors.initials: PM
authors.lastname: Pinheiro
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001379:Azathioprine / Q000627:therapeutic use; D003141:Communicable Diseases / Q000453:epidemiology; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011183:Postoperative Complications / Q000453:epidemiology; D012307:Risk Factors
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D009173:Mycophenolic Acid; D001379:Azathioprine